Press Releases

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

July 29, 2021

Ipsen delivers strong H1 2021 results and upgrades full-year guidance

Financial results | Financial results | Press Releases | Press releases | Regulated Information News Article

July 10, 2018

Ipsen welcomes Frédérique Vidal, Minister for Higher Education, Research and Innovation, to its new development centre in Dreux

Press Releases | Press releases News Article

June 3, 2018

Exelixis announces results from sub-group analyses of the phase 3 pivotal CELESTIAL trial of cabozantinib for advanced hepatocellular carcinoma presented at ASCO 2018

Other information | Press Releases News Article

May 30, 2018

Exelixis Announces U.S. FDA Accepts Supplemental New Drug Application for CABOMETYX (cabozantinib) in Previously Treated Advanced Hepatocellular Carcinoma

News | Other information | Press Releases News Article

May 22, 2018

IPSEN SPONSORS THE STROKE ACTION PLAN FOR EUROPE (2018-2030)

News | Other information | Press Releases News Article

May 3, 2018

Ipsen Neuroendocrine Tumor (NET) Expert Call, Wednesday, May 9th, 9:00am EST

Conferences & Roadshows | Press Releases News Article

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023